A detailed history of Boston Common Asset Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Boston Common Asset Management, LLC holds 152,532 shares of EW stock, worth $10.5 Million. This represents 0.67% of its overall portfolio holdings.

Number of Shares
152,532
Previous 207,924 26.64%
Holding current value
$10.5 Million
Previous $13.7 Million 17.71%
% of portfolio
0.67%
Previous 0.36%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025

SELL
$64.54 - $75.92 $3.57 Million - $4.21 Million
-55,392 Reduced 26.64%
152,532 $11.3 Million
Q3 2024

Oct 09, 2024

BUY
$59.7 - $93.78 $475,988 - $747,707
7,973 Added 3.99%
207,924 $13.7 Million
Q2 2024

Jul 08, 2024

SELL
$84.3 - $94.31 $448,391 - $501,634
-5,319 Reduced 2.59%
199,951 $18.5 Million
Q1 2024

Apr 11, 2024

SELL
$72.54 - $95.56 $1.51 Million - $1.99 Million
-20,836 Reduced 9.22%
205,270 $19.6 Million
Q4 2023

Jan 09, 2024

SELL
$61.71 - $77.76 $574,766 - $724,256
-9,314 Reduced 3.96%
226,106 $17.2 Million
Q3 2023

Oct 11, 2023

BUY
$69.28 - $93.38 $1.24 Million - $1.67 Million
17,928 Added 8.24%
235,420 $16.3 Million
Q2 2023

Jul 24, 2023

BUY
$81.41 - $94.33 $1.88 Million - $2.18 Million
23,123 Added 11.9%
217,492 $20.5 Million
Q1 2023

May 17, 2023

BUY
$74.26 - $84.51 $14.4 Million - $16.4 Million
194,369 New
194,369 $16.1 Million
Q2 2022

Aug 10, 2022

BUY
$86.5 - $128.27 $16,002 - $23,729
185 Added 8.53%
2,354 $224,000
Q1 2022

May 16, 2022

SELL
$101.96 - $128.34 $23,756 - $29,903
-233 Reduced 9.7%
2,169 $255,000
Q4 2021

Jan 31, 2022

BUY
$106.37 - $130.68 $34,995 - $42,993
329 Added 15.87%
2,402 $311,000
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $1,749 - $2,086
17 Added 0.83%
2,073 $235,000
Q2 2021

Aug 19, 2021

BUY
$83.84 - $104.76 $172,375 - $215,386
2,056 New
2,056 $212,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $42.7B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Boston Common Asset Management, LLC Portfolio

Follow Boston Common Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Common Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boston Common Asset Management, LLC with notifications on news.